Latest News

Albireo Unveils Plans for Phase 3 Clinical Program

Albireo Unveils Plans for Phase 3 Clinical Program

May 18, 2017 at 11:44 am 0 comments

Albireo Pharma, Inc. was out Thursday with key study design details for a planned phase 3 program of lead product candidate, A4250, in patients with progressive familial intrahepatic cholestasis (PFIC) determined following consultations with the U.S. Food and Drug Administration and European Medicines Agency. PFIC is a rare and life-threatening genetic liver disorder for which there are currently no approvedRead More

Coca-Cola Company Signs Deal With Distributor Reyes

Coca-Cola Company Signs Deal With Distributor Reyes

May 16, 2017 at 12:24 pm 0 comments

The Coca-Cola Company has signed a new letter of intent with Reyes Holdings, a food and beverage distribution company, for territory in California and Nevada. The territory includes the metropolitan markets of Los Angeles, San Francisco, San Diego and Las Vegas, Reyes said in a statement. The agreement involves the west operating unit of Coca-Cola Refreshments, which is part ofRead More

Cardiome Pharma Amends Term-Loan Agreement with CRG

Cardiome Pharma Amends Term-Loan Agreement with CRG

May 15, 2017 at 3:19 pm 0 comments

Cardiome Pharma said early Monday it has amended its term-loan agreement with CRG-managed funds originally entered into last June. The amended agreement now provides Cardiome with up to $50 million of available borrowing capacity. The amended loan matures on March 31, 2022. The revised agreement bears interest at 13% per annum. Interest payments may be split, at the company’s option,Read More

European ADRs Trading Lower

European ADRs Trading Lower

May 11, 2017 at 11:39 am 0 comments

American depository receipts of European stocks were 0.8% lower at 132.43 on the Bank of New York Mellon Europe ADR Index on Thursday morning. Decliners in Continental Europe were led by Spanish telecommunication company Telefonica (TEF), 4.3% lower after reporting first-quarter earnings, which showed an overall increase in revenue despite sales contractions in its Spanish, German and UK businesses duringRead More

BioTime Presents New Data on OpRegen

BioTime Presents New Data on OpRegen

May 9, 2017 at 1:04 pm 0 comments

BioTime shares were more than 2% higher in pre-market trading following the presentation of new data from the company’s phase I/IIa clinical trial of OpRegen for the treatment of advanced dry age-related macular degeneration. The results were presented Monday at the annual meeting of the Association for Research in Vision and Ophthalmology in Baltimore. Imaging analysis suggests the transplanted OpRegenRead More

Howard Hughes Shares Gain

Howard Hughes Shares Gain

May 8, 2017 at 4:18 pm 0 comments

Howard Hughes shares jumped more than 3% intraday, touching their highest level since August 2015, after billionaire hedge fund manager Bill Ackman made a bullish pitch for the company at the Sohn Investment Conference in New York, according to a report from CNBC. “I think this is one of the most attractive times in the history of the company toRead More

FormFactor Tops Estimates

FormFactor Tops Estimates

May 4, 2017 at 12:38 pm 0 comments

FormFactor rallied 21.5%, earlier hitting the highest level since April 2010, after the company said late Wednesday Q1 sales surged to $128.8 million from $53.6 million and topped the CapIQ mean for $124.1 million. Non-GAAP EPS swung to a profit of $0.24 from a loss of $0.11 last year and beat expectations for a profit of $0.20. Q2 sales areRead More